Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

INDP

Indaptus Therapeutics (INDP)

Indaptus Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:INDP
DateTimeSourceHeadlineSymbolCompany
01/02/202508:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INDPIndaptus Therapeutics Inc
23/01/202509:01Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:INDPIndaptus Therapeutics Inc
15/01/202508:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INDPIndaptus Therapeutics Inc
14/01/202500:00GlobeNewswire Inc.Indaptus Therapeutics, Inc. Announces $2.25 Million Private Placement Priced At-The-Market Under Nasdaq RulesNASDAQ:INDPIndaptus Therapeutics Inc
09/01/202500:00GlobeNewswire Inc.Indaptus Therapeutics Provides Year-End Review and Outlook for 2025NASDAQ:INDPIndaptus Therapeutics Inc
02/01/202516:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:INDPIndaptus Therapeutics Inc
24/12/202408:52Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:INDPIndaptus Therapeutics Inc
07/12/202408:36Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:INDPIndaptus Therapeutics Inc
23/11/202408:48Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INDPIndaptus Therapeutics Inc
23/11/202408:23Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:INDPIndaptus Therapeutics Inc
23/11/202400:36GlobeNewswire Inc.Indaptus Therapeutics, Inc. Announces $2.135 Million Registered Direct Offering and Concurrent Private PlacementNASDAQ:INDPIndaptus Therapeutics Inc
13/11/202400:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INDPIndaptus Therapeutics Inc
13/11/202400:00GlobeNewswire Inc.Indaptus Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:INDPIndaptus Therapeutics Inc
12/11/202400:00GlobeNewswire Inc.Indaptus Therapeutics’ Pioneering Research on Novel Immunotherapy Approach Published in Peer-Reviewed Frontiers in ImmunologyNASDAQ:INDPIndaptus Therapeutics Inc
08/11/202400:00GlobeNewswire Inc.Indaptus Therapeutics Presents Encouraging Interim Safety Data from Phase 1 Clinical Trial of Decoy20 at the Society for Immunotherapy of Cancer (SITC) 2024 Annual MeetingNASDAQ:INDPIndaptus Therapeutics Inc
23/10/202423:00GlobeNewswire Inc.Indaptus Therapeutics to Present at Two Upcoming Investor ConferencesNASDAQ:INDPIndaptus Therapeutics Inc
22/10/202423:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INDPIndaptus Therapeutics Inc
22/10/202423:00GlobeNewswire Inc.Indaptus Therapeutics Announces Clinical Supply Agreement with BeiGene to Evaluate Novel Cancer Treatment CombinationsNASDAQ:INDPIndaptus Therapeutics Inc
15/10/202423:00GlobeNewswire Inc.Indaptus Therapeutics Initiates Unrestricted Enrollment of Patients on Decoy20 Weekly Dosing Based on Encouraging Safety DataNASDAQ:INDPIndaptus Therapeutics Inc
11/10/202407:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INDPIndaptus Therapeutics Inc
10/10/202423:00GlobeNewswire Inc.Indaptus Therapeutics Founder and Chief Scientific Officer to Speak on Lumanity Webinar about the Future of Innate Immunity in Cancer ImmunotherapyNASDAQ:INDPIndaptus Therapeutics Inc
08/10/202423:00GlobeNewswire Inc.Indaptus Therapeutics to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual SummitNASDAQ:INDPIndaptus Therapeutics Inc
05/10/202407:21Edgar (US Regulatory)Form D/A - Notice of Exempt Offering of Securities: [Amend]NASDAQ:INDPIndaptus Therapeutics Inc
23/09/202414:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:INDPIndaptus Therapeutics Inc
13/09/202406:45Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:INDPIndaptus Therapeutics Inc
05/09/202422:30GlobeNewswire Inc.Indaptus Therapeutics Reports Encouraging New Safety Data for Decoy20 Clinical Program; Company Expands Enrollment of Patients on Weekly Dosing at Two Different DosesNASDAQ:INDPIndaptus Therapeutics Inc
03/09/202422:00GlobeNewswire Inc.Indaptus Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:INDPIndaptus Therapeutics Inc
23/08/202400:06Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:INDPIndaptus Therapeutics Inc
12/08/202422:16Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:INDPIndaptus Therapeutics Inc
12/08/202422:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:INDPIndaptus Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:INDP